ALK and neuroblastoma: Since ALK gene mutation has been proven to be a susceptibility factor and an important molecular driver for NB (36), the fact that ALK mutation frequency negatively correlated with pyroscore further increased our confidence in the efficacy of pyroscore as a marker for prognosis in NB patients.